Kidney Transplant Onconephrology: Immunotherapies, Engineered Cellular Therapies, and Management of Post-Transplant Lymphoproliferative Disorder
Back to course
Video Transcription
Video Summary
Asset Caption
Naoka Murakami, MD, PhD, FASN
Meta Tag
Speaker Naoka Murakami
Keywords
kidney transplant recipients
immune checkpoint inhibitors
organ rejection
post-transplant lymphoproliferative disorder
rituximab therapy
CAR-T cell therapy